Douglas A. Lauffenburger is Ford Professor of Bioengineering and Head of the Department of Biological Engineering at MIT, and also holds appointments in the Department of Biology and the Department of Chemical Engineering. He is a member of the Center for Biomedical Engineering (CBI), Center for Cancer Research, Center for Environmental Health Sciences, and Center for Gynepathology Research, and is Director of the Computational & Systems Biology Initiative.
Panel #1: Are We Organized for Failure? A Discussion of the US Healthcare Delivery System
Michael Porter, Ph.D. – Harvard University, author of 'Redefining Healthcare'
Recognized as the father of the modern strategy field, Porter's ideas are taught in virtually every business school in the world. His book "Redefining Healthcare" (written with Elizabeth Teisberg) develops a new strategic framework for transforming the value delivered by the healthcare system.
John Mendelsohn, M.D. – President, University of Texas MD Anderson Cancer Center
Dr. Mendelsohn has been at the forefront in understanding how growth factors regulate the proliferation of cancer cells by activating receptors on cell surfaces. He is the developer of the cancer therapy Erbitux™ and the founding editor of "Clinical Cancer Research."
Elizabeth G. Nabel, M.D. – President, Brigham and Women's (BWH) and Faulkner Hospitals
Prior to her position at BWH, a role she assumed on January 4, 2010, Dr. Nabel served as director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH). Among her leadership efforts as NHLBI director, Dr. Nabel launched new scientific programs in genetics and genomics, stem and progenitor cell biology,
|SOURCE Merrimack Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved